cik
stringclasses
1 value
date
stringlengths
8
8
form
stringclasses
4 values
sentenceCount
int64
0
2.33k
sentence
stringlengths
2
5.25k
filename
stringlengths
40
40
0000320193
20031219
10-K
1,152
The Company also enters into foreign currency forward and option contracts to offset the foreign exchange gains and losses generated by the re-measurement of certain recorded assets and liabilities denominated in non-functional currencies of its foreign subsidiaries.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,153
In order to provide a meaningful assessment of the foreign currency risk associated with certain of the Company's foreign currency derivative positions, the Company performed a sensitivity analysis using a value-at-risk (VAR) model to assess the potential impact of fluctuations in exchange rates.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,154
The VAR model consisted of using a Monte Carlo simulation to generate 3000 random market price paths.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,155
The VAR is the maximum expected loss in fair value, for a given confidence interval, to the Company's foreign exchange portfolio due to adverse movements in rates.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,156
The VAR model is not intended to represent actual losses but is used as a risk estimation and management tool.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,157
The model assumes normal market conditions.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,158
Forecasted transactions, firm commitments, and assets and liabilities denominated in foreign currencies were excluded from the model.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,159
Based on the results of the model, the Company estimates with 95% confidence a maximum one-day loss in fair value of $7.5 million as of September 27, 2003 compared to a maximum one-day loss of $3.8 million as of September 28, 2002.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,160
Because the Company uses foreign currency instruments for hedging purposes, losses incurred on those instruments are generally offset by increases in the fair value of the underlying exposures.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,161
Actual gains and losses in the future associated with the Company's investment portfolio and derivative positions may differ materially from the sensitivity analyses performed as of September 27, 2003 due to the inherent limitations associated with predicting the changes in the timing and amount of interest rates, fore...
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,162
Item 8.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,163
Financial Statements and Supplementary Data All financial statement schedules have been omitted, since the required information is not present or is not present in amounts sufficient to require submission of the schedule, or because the information required is included in the Consolidated Financial Statements and Notes...
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,164
CONSOLIDATED BALANCE SHEETS (In millions, except share amounts) See accompanying notes to consolidated financial statements.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,165
CONSOLIDATED STATEMENTS OF OPERATIONS (In millions, except share and per share amounts) See accompanying notes to consolidated financial statements.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,166
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (In millions, except share amounts which are in thousands) See accompanying notes to consolidated financial statements.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,167
CONSOLIDATED STATEMENTS OF CASH FLOWS (In millions) See accompanying notes to consolidated financial statements.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,168
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Note 1-Summary of Significant Accounting Policies Apple Computer, Inc. and its subsidiaries (the Company) designs, manufactures and markets personal computers and related software, peripherals and personal computing and communicating solutions.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,169
The Company's products include the Macintosh line of desktop and notebook computers, the Mac OS X operating system, the iPod digital music player, and a portfolio of software products and peripherals for education, creative, consumer and business customers.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,170
The Company sells its products through its online stores, direct sales force, third-party wholesalers and resellers, and its own retail stores.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,171
Basis of Presentation and Preparation The accompanying consolidated financial statements include the accounts of the Company.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,172
Intercompany accounts and transactions have been eliminated.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,173
The preparation of these consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in these consolidated financial statements and accompanying notes.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,174
Actual results could differ materially from those estimates.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,175
Certain prior year amounts in the consolidated financial statements and notes thereto have been reclassified to conform to the current year presentation.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,176
Typically, the Company's fiscal year ends on the last Saturday of September.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,177
Fiscal years 2003, 2002 and 2001 were each 52-week years.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,178
However, approximately every six years, the Company reports a 53-week fiscal year to align its fiscal quarters with calendar quarters by adding a week to its first fiscal quarter.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,179
All information presented herein is based on the Company's fiscal calendar.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,180
Financial Instruments Cash Equivalents and Short-term Investments The Company places its short-term investments in highly liquid securities issued by high credit quality issuers.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,181
All highly liquid investments with maturities of three months or less at the date of purchase are classified as cash equivalents; highly liquid investments with maturities greater than three months are classified as short-term investments.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,182
Management determines the appropriate classification of its investments in debt and marketable equity securities at the time of purchase and reevaluates such designation as of each balance sheet date.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,183
The Company's debt and marketable equity securities have been classified and accounted for as available-for-sale.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,184
These securities are carried at fair value, with the unrealized gains and losses, net of taxes, reported as a component of shareholders' equity.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,185
The cost of securities sold is based upon the specific identification method.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,186
Non-Current Debt and Equity Investments The Company has made investments in non-current debt and equity investments of public and privately held companies that have been reflected in the consolidated balance sheets as long-term assets within other assets.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,187
They are not categorized as current assets either because, given their nature, they are not readily convertible into cash or because they represent potentially longer-term investments by the Company.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,188
Further, the fair value of these investments has been subject to a high degree of volatility.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,189
The Company's non-current debt and equity investments have been categorized as available-for-sale requiring that they be carried at fair value with unrealized gains and losses, net of taxes, reported in equity as a component of accumulated other comprehensive income.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,190
However, the Company recognizes an impairment charge to earnings in the event a decline in fair value below the cost basis of one of these investments is determined to be other-than-temporary.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,191
The Company includes recognized gains and losses resulting from the sale or from other-than-temporary declines in fair value associated with these investments in other income and expense.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,192
Occasionally, the Company uses short-term equity derivatives to manage potential dispositions of non-current debt and equity investments.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,193
Any gains or losses associated with such derivatives are recognized currently in other income and expense.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,194
Financial Instruments with Characteristics of Both Liabilities and Equity On May 15, 2003, the Financial Accounting Standards Board (FASB) issued Statement of Financial Accounting Standards (SFAS) No.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,195
150, Accounting for Certain Financial Instruments with Characteristics of Both Liabilities and Equity.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,196
SFAS No.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,197
150 requires issuers to classify as liabilities (or assets in some circumstances) certain freestanding financial instruments that embody obligations for the issuer and have characteristics of both liabilities and equity.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,198
The Company adopted the provisions of SFAS No.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,199
150 on June 29, 2003, which resulted in a favorable cumulative-effect type adjustment of approximately $3 million.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,200
This adjustment related to a forward purchase agreement that allowed the Company to acquire 1.5 million shares of its common stock at an average price of $16.64 per share for a total cost of $25.5 million.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,201
The Company settled this forward purchase agreement in August 2003, which resulted in an additional gain of approximately $6 million representing the increase in fair value of the agreement from June 29, 2003 through the settlement date.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,202
Derivative Financial Instruments On October 1, 2000, the Company adopted SFAS No.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,203
133, Accounting for Derivative Instruments and Hedging Activities.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,204
SFAS No.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,205
133 establishes accounting and reporting standards for derivative instruments, hedging activities, and exposure definition.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,206
SFAS No.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,207
133 requires that all derivatives be recognized as either assets or liabilities at fair value.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,208
Derivatives that are not hedges must be adjusted to fair value through income.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,209
If the derivative is a hedge, depending on the nature of the hedge, changes in fair value will either be offset against the change in fair value of the hedged assets, liabilities, or firm commitments through earnings, or recognized in other comprehensive income until the hedged item is recognized in earnings.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,210
Net of the related income tax effect of approximately $5 million, adoption of SFAS No.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,211
133 resulted in a favorable cumulative-effect type adjustment to net income of approximately $12 million.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,212
Net of the related income tax effect of approximately $5 million, adoption of SFAS No.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,213
133 resulted in a favorable cumulative-effect-type adjustment to other comprehensive income of approximately $12 million, all of which was reclassified to earnings during 2001.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,214
Management does not believe that ongoing application of SFAS No.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,215
133 will significantly alter the Company's hedging strategies.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,216
However, its application may increase the volatility of other income and expense and other comprehensive income.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,217
For derivative instruments that hedge the exposure to variability in expected future cash flows that are attributable to a particular risk and that are designated as cash flow hedges, the net gain or loss on the derivative instrument is reported as a component of other comprehensive income in shareholders' equity and r...
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,218
To receive hedge accounting treatment, cash flow hedges must be highly effective in achieving offsetting changes to expected future cash flows on hedged transactions.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,219
For derivative instruments that hedge the exposure to changes in the fair value of an asset or a liability or an identified portion thereof that are attributable to a particular risk and that are designated as fair value hedges, the net gain or loss on the derivative instrument as well as the offsetting gain or loss on...
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,220
The net gain or loss on the effective portion of a derivative instrument that is designated as an economic hedge of the foreign currency translation exposure of the net investment in a foreign operation is reported in the same manner as a foreign currency translation adjustment.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,221
For forward contracts designated as net investment hedges, the Company excludes changes in fair value relating to changes in the forward carry component from its definition of effectiveness.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,222
Accordingly, any gains or losses related to this component are recognized in current earnings.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,223
For derivative instruments not designated as hedging instruments, changes in fair value are recognized in earnings in the current period.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,224
For foreign currency forward contracts designated as cash flow hedges, hedge effectiveness is measured based on changes in the fair value of the contract attributable to changes in the forward exchange rate.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,225
Changes in the expected future cash flows on the forecasted hedged transaction and changes in the fair value of the forward hedge are both measured from the contract rate to the forward exchange rate associated with the forward contract's maturity date.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,226
For currency option contracts, hedge effectiveness is measured based on changes in the total fair value of the option contract.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,227
Hedge effectiveness is assessed by comparing the present value of the cumulative change in expected future cash flows on the hedged transaction to changes in expected cash flow of the option hedge at maturity.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,228
The net gains or losses on derivative instruments qualifying as cash flow hedges are reported as components of other comprehensive income in shareholders' equity and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,229
Any hedge ineffectiveness is recognized in current earnings in other income and expense.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,230
For interest rate swap agreements qualifying as fair value hedges, the Company assumes no ineffectiveness because these swaps meet the criteria for accounting under the short-cut method defined in SFAS No.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,231
133.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,232
Inventories Inventories are stated at the lower of cost (first-in, first-out) or market.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,233
If the cost of the inventories exceeds their market value, provisions are made currently for the difference between the cost and the market value.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,234
Property, Plant, and Equipment Property, plant, and equipment are stated at cost.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,235
Depreciation is computed by use of the declining balance and straight-line methods over the estimated useful lives of the assets, which are 30 years for buildings, from 2 to 5 years for equipment, and the shorter of lease terms or 10 years for leasehold improvements.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,236
The Company capitalizes eligible costs to acquire or develop internal-use software that are incurred subsequent to the preliminary project stage.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,237
Capitalized costs related to internal-use software are amortized using the straight-line method over the estimated useful lives of the assets, which range from 3 to 5 years.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,238
Asset Retirement Obligations On September 29, 2002, the Company adopted SFAS No.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,239
143, Accounting for Asset Retirement Obligations, which addresses financial accounting and reporting for obligations associated with the retirement of tangible long-lived assets and the associated asset retirement costs.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,240
The standard applies to legal obligations associated with the retirement of long-lived assets that result from the acquisition, construction, development and/or normal use of the assets.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,241
SFAS No.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,242
143 requires that the fair value of a liability for an asset retirement obligation be recognized in the period in which it is incurred if a reasonable estimate of fair value can be made.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,243
The fair value of the liability is added to the carrying amount of the associated asset and this additional carrying amount is depreciated over the life of the asset.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,244
All of the Company's existing asset retirement obligations are associated with commitments to return property subject to operating leases to original condition upon lease termination.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,245
The Company estimated that as of September 29, 2002, gross expected future cash flows of $9.5 million would be required to fulfill these obligations.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,246
As of the date of adoption, the Company recorded a $6 million long-term asset retirement liability and a corresponding increase in leasehold improvements.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,247
This amount represents the present value of expected future cash flows associated with returning certain of the Company's leased properties to original condition.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,248
The difference between the gross expected future cash flow of $9.5 million and its present value of $6 million at September 29, 2002, is being accreted over the life of the related leases as an operating expense.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,249
Net of the related income tax effect of approximately $1 million, adoption of SFAS No.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,250
143 resulted in an unfavorable cumulative-effect type adjustment to net income during the first quarter of 2003 of approximately $2 million.
0001047469-03-041604/full-submission.txt
0000320193
20031219
10-K
1,251
This adjustment represents cumulative depreciation and accretion that would have been recognized through the date of adoption of SFAS No.
0001047469-03-041604/full-submission.txt